| | Unaudited For the Fiscal Year Ended | |
(Amounts in thousands) | | 4/27/2019 | | 4/28/2018 | |
Cash flows from operating activities | | | | | |
Net income | | $ | 70,141 | | $ | 81,595 | |
Adjustments to reconcile net income to cash provided by operating activities | | | | | |
Gain on disposal of assets | | (325 | ) | (2,108 | ) |
Gain on conversion of investment | | — | | (2,204 | ) |
Gain on sale of investments | | (656 | ) | (770 | ) |
Change in deferred taxes | | (1,668 | ) | 17,261 | |
Change in provision for doubtful accounts | | 502 | | 276 | |
Depreciation and amortization | | 31,147 | | 31,767 | |
Stock-based compensation expense | | 10,981 | | 9,474 | |
Pension termination charge | | 32,671 | | — | |
Pension plan contributions | | (7,000 | ) | (2,000 | ) |
Change in receivables | | 7,195 | | (2,801 | ) |
Change in inventories | | 3,135 | | (8,009 | ) |
Change in other assets | | (7,737 | ) | (3,245 | ) |
Change in accounts payable | | (2,388 | ) | 6,602 | |
Change in other liabilities | | 14,747 | | (10,088 | ) |
Net cash provided by operating activities | | 150,745 | | 115,750 | |
Cash flows from investing activities | | | | | |
Proceeds from disposals of assets | | 1,941 | | 1,440 | |
Proceeds from property insurance | | 184 | | 2,087 | |
Capital expenditures | | (48,433 | ) | (36,337 | ) |
Purchases of investments | | (20,698 | ) | (28,593 | ) |
Proceeds from sales of investments | | 20,944 | | 22,674 | |
Acquisitions, net of cash acquired | | (76,505 | ) | (16,495 | ) |
Net cash used for investing activities | | (122,567 | ) | (55,224 | ) |
Cash flows from financing activities | | | | | |
Payments on debt | | (223 | ) | (262 | ) |
Payments for debt issuance costs | | — | | (231 | ) |
Stock issued for stock and employee benefit plans, net of shares withheld for taxes | | 13,901 | | 2,977 | |
Purchases of common stock | | (22,957 | ) | (56,730 | ) |
Dividends paid | | (23,508 | ) | (22,009 | ) |
Net cash used for financing activities | | (32,787 | ) | (76,255 | ) |
Effect of exchange rate changes on cash and equivalents | | (475 | ) | 1,741 | |
Change in cash, cash equivalents and restricted cash | | (5,084 | ) | (13,988 | ) |
Cash, cash equivalents and restricted cash at beginning of period | | 136,871 | | 150,859 | |
Cash, cash equivalents and restricted cash at end of period | | $ | 131,787 | | $ | 136,871 | |
| | | | | |
Supplemental disclosure of non-cash investing activities | | | | | |
Capital expenditures included in accounts payable | | $ | 3,250 | | $ | 5,667 | |